The human leukocyte antigen (HLA) market is projected to reach US$ 1,155.65 million by 2028 from US$ 697.74 million in 2021; it is expected to register a CAGR of 7.5% from 2022 to 2028.
The increasing number of plasma donation and organ transplantation procedures and expanding range of applications of HLA testing are driving the market growth. However, errors in accuracy hamper the human leukocyte antigen (HLA) market growth. Human leukocyte antigens (HLAs) are the specialized proteins present on all cell surfaces of the human body, except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice worldwide. According to data published in Global Observatory on Donation and Transplantation (GODT), in 2020, 129,681 organ transplants were recorded in total. Of these, 31.7% were living kidney transplants and 20.40% were living liver transplants.
Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures. For Instance, the Organ Procurement and Transplantation Network (OPTN) has implemented a few strategies to improve the number of organ transplantation procedures in the US. These strategies focus on increasing the number of organ and tissue transplants among patients with end-stage organ disease, altering the current organ distribution, and modifying the organ transplantation waitlist by redistributing the existing organ soppy. Furthermore, the OPTN has used out-of-box strategies to improve organ transplantation. These innovative strategies include the optimized use of organs obtained from deceased patients [e.g., donation after cardiac death (DCD) or brain-dead donors], reducing discards of organs, promoting living donation, and improving the rate of potential organ donation authorization. Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, which drives the growth of the HLA testing market.
Based on product and services, the human leukocyte antigen (HLA) market is segmented into reagents and consumables, instruments, and software and services. In 2021, the reagents and consumables segment held the largest share of the market. Furthermore, it is expected to register the fastest CAGR of 7.5% during the forecast period.
Based on technology, the human leukocyte antigen (HLA) market is segmented into molecular assay technologies and non-molecular assay technologies. In 2021, the molecular assay technologies segment held a larger share of the market. It is expected to report a higher CAGR of 7.7% during 2022-2028.
Based on end user, the human leukocyte antigen (HLA) market is segmented into independent reference laboratories, hospitals and transplant centers, and others. In 2021, the independent reference laboratories segment held the largest share of the market. On the other hand, the hospitals and transplant centers segment is expected to report the highest CAGR of 7.9% during 2022-2028.
The Global Observatory on Donation and Transplantation (GODT), American Red Cross Organization, US Human Resource and Service Administration (HRSA), Canadian Institute for Health Information, National Registry of Transplants, German Society for Thoracic and Cardiovascular Surgery (GSTCVS), UK Health Security Agency, Spanish National Transplant Organisation (ONT), Japan Organ Transplant Network (JOTN), Saudi Center for Organ Transplantation (SCOT), Business Monitor International (BMI), South African Bone Marrow Registry (SABMR), and World Health Organization (WHO) are among the major secondary sources referred to while preparing the report on the human leukocyte antigen (HLA) market.
The increasing number of plasma donation and organ transplantation procedures and expanding range of applications of HLA testing are driving the market growth. However, errors in accuracy hamper the human leukocyte antigen (HLA) market growth. Human leukocyte antigens (HLAs) are the specialized proteins present on all cell surfaces of the human body, except red blood cells. HLA testing has significant application in organ transplantation, which can be recommended as a part of the treatment of kidney failure, chronic liver cirrhosis, and chronic heart disease, among other medical issues. The growing prevalence of chronic diseases and organ failure leads to high demand for organ transplant procedures, as well as HLA testing. Before transplantation, HLA testing is performed to check tissue compatibility between patients and donors to avoid graft rejection. In recent years, transplantation has become a successful practice worldwide. According to data published in Global Observatory on Donation and Transplantation (GODT), in 2020, 129,681 organ transplants were recorded in total. Of these, 31.7% were living kidney transplants and 20.40% were living liver transplants.
Governments of various countries are taking initiatives to spread awareness about the need for organ donation and the benefits of organ transplantation in certain treatment procedures. For Instance, the Organ Procurement and Transplantation Network (OPTN) has implemented a few strategies to improve the number of organ transplantation procedures in the US. These strategies focus on increasing the number of organ and tissue transplants among patients with end-stage organ disease, altering the current organ distribution, and modifying the organ transplantation waitlist by redistributing the existing organ soppy. Furthermore, the OPTN has used out-of-box strategies to improve organ transplantation. These innovative strategies include the optimized use of organs obtained from deceased patients [e.g., donation after cardiac death (DCD) or brain-dead donors], reducing discards of organs, promoting living donation, and improving the rate of potential organ donation authorization. Thus, the growing demand for organ transplantation leads to the requirement of a more substantial number of HLA testing kits and consumables, which drives the growth of the HLA testing market.
Based on product and services, the human leukocyte antigen (HLA) market is segmented into reagents and consumables, instruments, and software and services. In 2021, the reagents and consumables segment held the largest share of the market. Furthermore, it is expected to register the fastest CAGR of 7.5% during the forecast period.
Based on technology, the human leukocyte antigen (HLA) market is segmented into molecular assay technologies and non-molecular assay technologies. In 2021, the molecular assay technologies segment held a larger share of the market. It is expected to report a higher CAGR of 7.7% during 2022-2028.
Based on end user, the human leukocyte antigen (HLA) market is segmented into independent reference laboratories, hospitals and transplant centers, and others. In 2021, the independent reference laboratories segment held the largest share of the market. On the other hand, the hospitals and transplant centers segment is expected to report the highest CAGR of 7.9% during 2022-2028.
The Global Observatory on Donation and Transplantation (GODT), American Red Cross Organization, US Human Resource and Service Administration (HRSA), Canadian Institute for Health Information, National Registry of Transplants, German Society for Thoracic and Cardiovascular Surgery (GSTCVS), UK Health Security Agency, Spanish National Transplant Organisation (ONT), Japan Organ Transplant Network (JOTN), Saudi Center for Organ Transplantation (SCOT), Business Monitor International (BMI), South African Bone Marrow Registry (SABMR), and World Health Organization (WHO) are among the major secondary sources referred to while preparing the report on the human leukocyte antigen (HLA) market.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Human Leukocyte Antigen (HLA) Testing Market - By Product and Services
1.3.2 Global Human Leukocyte Antigen (HLA) Testing Market - By Technology
1.3.3 Global Human Leukocyte Antigen (HLA) Testing Market - By End User
1.3.4 Global Human Leukocyte Antigen (HLA) Testing Market - By Geography
2. Human Leukocyte Antigen (HLA) Testing Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Human Leukocyte Antigen (HLA) Testing Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa - PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion
5. Human Leukocyte Antigen (HLA) Testing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Number of Plasma Donation and Organ Transplantation Procedures
5.1.2 Expanding Range of Applications of HLA Testing
5.2 Market Restraints
5.2.1 Errors in Accuracy
5.3 Market Opportunities
5.3.1 Rising Government Funding for Organ Donation
5.4 Future Trends
5.4.1 Technological Advancements in Field of Histocompatibility
5.5 Impact Analysis
6. Global Human Leukocyte Antigen (HLA) Testing Market - Global Analysis
6.1 Global Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
6.1.1 Global Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis
6.1.2 Global Human Leukocyte Antigen (HLA) Testing Market - Market Potential Analysis, By Region
6.2 Company Analysis
6.2.1 Market Positioning of Key Players in Human Leukocyte Antigen (HLA) Testing Market
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance of Key Players
6.2.4.1 Thermo Fisher Scientific Inc
6.2.4.2 Illumina Corporation
7. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 - by Product and Services
7.1 Overview
7.2 Global Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)
7.3 Reagents and Consumables
7.3.1 Overview
7.3.2 Reagents and Consumables: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
7.5 Software and Services
7.5.1 Overview
7.5.2 Software and Services : Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
8. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by Technology
8.1 Overview
8.2 Global Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)
8.3 Molecular Assay Technologies
8.3.1 Overview
8.3.2 Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 PCR-Based Molecular Assays
8.3.3.1 Overview
8.3.3.2 PCR-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Sequencing-Based Molecular Assays
8.3.4.1 Overview
8.3.4.2 Sequencing-Based Molecular Assays: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.3.5 Others
8.3.5.1 Overview
8.3.5.2 Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Molecular Assay Technologies
8.4.1 Overview
8.4.2 Non-Molecular Assay Technologies: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by End User
9.1 Overview
9.2 Global Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)
9.3 Independent Reference Laboratories
9.3.1 Overview
9.3.2 Independent Reference Laboratories: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.4 Hospital & Transplant Centers
9.4.1 Overview
9.4.2 Hospital & Transplant Centers: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10. Global Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028- by Geography
10.1 North America: Human Leukocyte Antigen (HLA) Testing Market
10.1.1 Overview
10.1.2 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.4 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.4.1 North America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.5 North America: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6 North America: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
10.1.6.1 US: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.2 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.1.3 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.1.3.1 US: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.1.4 US: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6.2 Canada: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.2 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.2.3 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.2.3.1 Canada: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.2.4 Canada: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.1.6.3 Mexico: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Mexico Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.2 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.1.6.3.3 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.3.3.1 Mexico: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.1.6.3.4 Mexico: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2 Europe: Human Leukocyte Antigen (HLA) Testing Market
10.2.1 Overview
10.2.2 Europe: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.4 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.4.1 Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.5 Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6 Europe: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
10.2.6.1 Germany: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Germany: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.2 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.1.3 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.1.3.1 Germany: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.1.4 Germany: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6.2 France: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 France: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.2 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.2.3 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.2.3.1 France: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.2.4 France: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6.3 UK: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 UK: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.2 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.3.3 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.3.3.1 UK: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.3.4 UK: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6.4 Italy: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Italy: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.2 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.4.3 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.4.3.1 Italy: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.4.4 Italy: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6.5 Spain: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Spain: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.2 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.5.3 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.5.3.1 Spain: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.5.4 Spain: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.2.6.6 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.2 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.2.6.6.3 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.6.3.1 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.2.6.6.4 Rest of Europe: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.3 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028
10.3.1 Overview
10.3.2 Asia Pacific Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.3.4 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.4.1 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.5 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6 Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Country (2022 & 2028) (%)
10.3.6.1 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
10.3.6.1.1 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.2 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.1.3 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.1.3.1 China: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.1.4 China: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.2 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.2 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.2.3 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.2.3.1 Japan: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.2.4 Japan: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.3 India Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
10.3.6.3.1 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.2 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.3.3 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.3.3.1 India: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.3.4 India: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.4 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)
10.3.6.4.1 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.2 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.4.3 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.4.3.1 South Korea: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.4.4 South Korea: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.5 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.2 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.5.3 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.5.3.1 Australia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.5.4 Australia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.6 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.2 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By Technology (US$ Million)
10.3.6.6.3.1 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028, By End User (US$ Million)
10.4 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.4.4 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.4.1 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.5 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6 Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)
10.4.6.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.2 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.4.6.1.3 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.1.3.1 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.1.4 Saudi Arabia: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6.2 UAE: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 UAE: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.2 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.4.6.2.3 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.2.3.1 UAE: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.2.4 UAE: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6.3 South Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 South Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.2 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.4.6.3.3 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.3.3.1 South Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.3.4 South Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6.4 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.2 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.4.3.1 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)
10.5 South and Central America Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028
10.5.1 Overview
10.5.2 South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.5.3 South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By Product and Services (US$ Million)
10.5.4 South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
10.5.4.1 South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.5.5 South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
10.5.6 South and Central America: Human Leukocyte Antigen (HLA) Testing Market Share, by Country (2022 & 2028) (%)
10.5.6.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.2 Brazil: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By product and service (US$ Million)
10.5.6.1.3 Brazil: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3.1 Brazil: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.5.6.1.4 Brazil: Human Leukocyte Antigen (HLA) Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Argentina: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Argentina: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.2 Argentina: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By product and service (US$ Million)
10.5.6.2.3 Argentina: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3.1 Argentina: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.5.6.2.4 Argentina: Human Leukocyte Antigen (HLA) Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.2 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028, By product and service (US$ Million)
10.5.6.3.3 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3.1 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)
10.5.6.3.4 Rest of South and Central America: Human Leukocyte Antigen (HLA) Testing Market, by End User- Revenue and Forecast to 2028 (US$ Million)
11. Impact of COVID-19 Pandemic on Geographic Regions
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment Of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment Of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Human Leukocyte Antigen (HLA) Testing Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Human Leukocyte Antigen (HLA) Testing Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 CareDx
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Illumina, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bio-Rad Laboratories, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 TBG Diagnostics Limited
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 F. HOFFMANN-LA ROCHE LTD.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Takara Bio Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Luminex Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Omixon Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 The Sequencing Center
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Protrans
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 HistoGenetics LLC
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 CD Genomics
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Quintara Biosciences
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 CeGaT GmbH
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 CREATIVE BIOLABS, INC.
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
Companies Mentioned
- Thermo Fisher Scientific Inc.
- CareDx
- Qiagen
- Illumina Inc.
- Bio-Rad Laboratories, Inc.
- TBG Diagnostics Limited
- F.Hoffmann-La Roche Ltd.
- Takara Bio Inc.
- Luminex Corporation
- Omixon Inc.
- The Sequencing Center
- Protrans
- Hist
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 221 |
| Published | May 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( $ | $ 748.82 million |
| Forecasted Market Value ( $ | $ 1155.65 million |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
